OCTA in Cardiovascular Disease and Healthy Controls
Recruiting now · Not applicable
Conditions studied: Patients With Cardiovascular Disease, Healthy Participants
In brief
This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.
Key facts
- Study ID
- NCT07359664
- Run by
- University of Erlangen-Nürnberg Medical School
- People needed
- 64
- Starts
- 2025-12-01
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2026-01-22
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Erlangen Nuremberg — Erlangen, Bavaria, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.